Shanghai Hanhong Chemical Co., Ltd.
China |
|
| | |
|
| PT-141 |
(Product Photo) |
| | PT-141 is Palatin¡ ¯ s novel drug candidate for the treatment of male and female sexual dysfunction. First in a new class of therapies called melanocortin agonists, PT-141 has shown promise in effectively treating erectile dysfunction ( ED) without the cardiovascular effects found in ED drugs currently available. PT-141 works through a mechanism of action involving the central nervous system rather than directly on the vascular system. As a result, it may offer significant safety and efficacy benefits over currently available products. To date, PT-141 has shown positive results in four Phase 2 efficacy studies enrolling more than 300 men. Palatin has also conducted a Phase 1 study in 32 premenopausal women without sexual dysfunction, in which the drug was shown to be safe and well tolerated. A Phase 2A pilot clinical study evaluating PT-141 in pre-menopausal women diagnosed with female sexual dysfunction ( FSD) has shown encouraging results | | |
|
| Origin: | China |
| Payment Method: | Western Union |
| Quantity: | 100mg |
| Pack. & Delivery: | 10mg/vial |
Your inquiry will be recorded in "Member Trade Mail". |
Recommend to your friends |
|
| Company Contact |
| Name: |
Mr. ÂíÊ¿Ç¿ [Sales] |
| E-mail: |
Jerry@hanhongchem.com |
| Homepage: |
http://www.hanhongpeptide.com |
| Instant Messaging |
|
| Phone Number: |
86-21-64543801 |
| Fax Number: |
86-21-54291107 |
| Address: |
Room 207,No.1 Building,No.245 Jiachuan Road, Xuhui District, Shanghai, China
Shanghai 200237, Shanghai
China |
|
)
